Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Jasper Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for JSPR.
You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.
Other companies in Jasper Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), OncoCyte (NASDAQ:OCX), Elicio Therapeutics (NASDAQ:ELTX) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Jasper Therapeutics has a consensus price target of $49.82.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $5.41 last updated May 2, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics’s Q1 earnings are confirmed for Friday, May 16, 2025.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.